Kagan and Soai win 2026 Nobel Chemistry for molecular shape control in drug design

Henri Kagan and Kenso Soai have been awarded the 2026 Nobel Prize in Chemistry for developing methods to control the chirality of molecules, a key factor in drug efficacy and safety. The award highlights the practical impact of asymmetric synthesis on pharmaceutical manufacturing, though specific applications and market implications remain unspecified.